FDA warned Filler Lux USA that it sells unapproved injectable lipolytic drugs online without FDA approval.
What happened
FDA reviewed fillerx.com in December 2024 and an Instagram page that directs consumers to it, and found injectable lipolytic products offered for sale with claims to dissolve fat and affect body structure. FDA said the products are drugs and new drugs without approved applications.
What FDA found
The website sells injectable lipolytic products with claims that they dissolve fat or affect body structure, so FDA treats them as drugs.
21 U.S.C. 321(g)(1)The products are new drugs because FDA does not generally recognize them as safe and effective for those uses.
21 U.S.C. 321(p)The company introduced or delivered the products for interstate commerce without an FDA-approved drug application.
21 U.S.C. 355(a); 21 U.S.C. 331(d)No approved applications under section 505 are in effect for these products.
21 U.S.C. 355
What FDA wants
FDA asks the company to notify it in writing within 15 working days of steps taken to correct the violations and prevent recurrence, with supporting documents. If the company disagrees, it must explain why and provide support; if it cannot finish, it must give the reason and completion date.
Who should pay attention
- clinics and med spas buying injectable fat-dissolving products
- online retailers and distributors of aesthetic injectables
- consumers considering unapproved injectable lipolytic products
This is a summary. Read the original letter on fda.gov.